Skip to main content

Table 4 Comparison of HR-HPV prevalence and genotypic distribution in screening settings in various countries

From: Genotypic distribution of human papillomavirus (HPV) and cervical cytology findings in 5906 Thai women undergoing cervical cancer screening programs

Study/year Site/N HPV Test HR-HPV* 16 18 31 33 35 39 45 51 52 56 58 59
N (%)
Ralston Howe E (15) USA PCR 13444 4507 881 1757 524 479 306 734 26 2009 437 865 919
2009 73371   (18.3) (33.5) (6.6) (13.1) (3.9) (3.6) (2.3) (5.5) (0.2) (14.9) (3.3) (6.4) (6.8)
Dickson EL (16) ** USA PCR 11.9% 4.1% 0.7% 1.9% 0.4% 0.3%   0.5% - 2.1% - 1.1% 0.8%
2013 309471   (100) (34.5) (5.9) (16.0) (3.4) (2.5) - (4.2)   (17.6)   (9.2) (6.7)
Agarossi A (17) Italy HC2 followed by PCR 1403 415 150 211 61 67 111 68 132 67 142 120 45
2009 9946 (14.1) (29.6) (10.7) (15.0) (4.3) (4.8) (7.9) (4.8) (9.4) (4.8) (10.1) (8.6) (3.2)
Anderson L (18) ** Ireland Cobas4800 test followed by Linear array 16.6% 3.2% 1.2% 1.8% 1.2% 0.5% 1.2% 1.0% 1.6% 1.5% 1.0% 0.8% 1.6%
2012 5712 (100) (19.3) (7.2) (10.8) (7.2) (3.0) (7.2) (6.0) (9.6) (9.0) (6.0) (4.8) (9.6)
Ucakar V (19) Slovenia HC2/Real Time PCR followed by Linear array 502 155 46 114 32 9 50 42 81 78 31 29 29
2012 4431 (11.3) (30.9) (9.2) (22.7) (6.4) (1.8) (10.0) (8.4) (16.1) (15.5) (6.2) (5.8) (5.8)
INOUE M (23) Japan HC2 followed by HPVDNAChip (Biomedlab Co., South Korea) 632 167 73 50 17 7 43 20 98 189 100 131 39
2006 8156 (7.7) (22.7) (9.9) (6.8) (2.3) (1.0) (5.9) (2.7) (13.3) (25.7) (13.6) (17.8) (5.3)
Li H (24) China HPV GenoArray (Hybribio, Hong Kong) 755 233 64 26 30 3 44 9 20 163 27 119 17
2013 3640 (20.7) (30.9) (8.5) (3.4) (4.0) (0.4) (5.8) (1.2) (2.6) (21.5) (3.6) (15.8) (2.3)
Zhoa FH (31) China SPF PCR-DEIA-LiPA (LaboBiomedial Product, Rijswijk, the Netherlands) 924 222 74 59 65 31 81 33 102 243 69 90 22
2014 6035 (15.3) (3.7) (1.2) (1.0) (1.1) (0.5) (1.3) (0.5) (1.7) (4.0) (1.1) (1.5) (0.4)
This study Thailand Linear array (Roche, USA) 376 80 35 18 13 7 33 11 55 94 19 47 18
2015 5906
(6.4) (21.2) (9.3) (4.8) (3.5) (1.9) (8.8) (2.9) (14.6) (25.0) (5.1) (12.5) (4.8)
  1. *HR-HPV included 12 HPV types as 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, and 59.
  2. **Reported as percentage in total population.
  3. HC2: Hybrid Capture 2 (Qiagen, Hilden, Germany), PCR: polymerase chain reaction.